NCT00740129 - Re-treatment of Participants With Paget's Disease Using Zoledronic Acid | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 21, 2008

Primary Completion Date

March 14, 2011

Study Completion Date

March 14, 2011

Conditions

Paget's Disease of the Bone

Interventions

DRUG

Zoledronic Acid

Zoledronic acid 5 mg intravenous infusion once

Trial Locations (11)

Novartis Investigative site, Brussels

Novartis Investigative site, Montreal

Novartis Investigative site, Québec

Novartis Investigative site, Auckland

Novartis Investigative site, Cape Town

Novartis Investigative site, Barcelona

Novartis Investigative site, Madrid

Novartis Investigative site, Salamanca

Novartis Investigative site, Valencia

Novartis Investigative site, Nottingham

Novartis Investigative site, Oxford